INmune Bio (NASDAQ:INMB) Earns Outperform Rating from Analysts at Raymond James
Raymond James assumed coverage on shares of INmune Bio (NASDAQ:INMB – Free Report) in a research report released on Friday morning, MarketBeat Ratings reports. The firm issued an outperform rating and a $18.00 target price on the stock. Separately, Scotiabank started coverage on shares of INmune Bio in a research note on Thursday, August 22nd. […]
More Stories
TMT Acquisition Corp (NASDAQ:TMTC) Short Interest Up 25.8% in September
TMT Acquisition Corp (NASDAQ:TMTC – Get Free Report) was the target of a significant growth in short interest in the...
Sound Group Inc. (NASDAQ:SOGP) Sees Significant Decrease in Short Interest
Sound Group Inc. (NASDAQ:SOGP – Get Free Report) saw a large decline in short interest in the month of September....
Safety Shot, Inc. (NASDAQ:SHOT) Short Interest Down 18.2% in September
Safety Shot, Inc. (NASDAQ:SHOT – Get Free Report) saw a large decline in short interest in the month of September....
Russel Metals Inc. (OTCMKTS:RUSMF) Short Interest Update
Russel Metals Inc. (OTCMKTS:RUSMF – Get Free Report) was the target of a large growth in short interest in September....
Petrus Resources Ltd. (OTCMKTS:PTRUF) Short Interest Update
Petrus Resources Ltd. (OTCMKTS:PTRUF – Get Free Report) saw a large increase in short interest during the month of September....
Short Interest in Pennon Group Plc (OTCMKTS:PEGRY) Declines By 14.6%
Pennon Group Plc (OTCMKTS:PEGRY – Get Free Report) was the target of a large drop in short interest during the...